Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia
Clinical trial NCT02746952 · COMPLETED
Trial details
- NCT number
- NCT02746952
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-07-28
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.